Propensity score analysis comparing survival between definitive chemoradiotherapy and esophagectomy with adjuvant chemoradiotherapy in patients with esophageal squamous cell carcinoma.
Yi-Lin ChangYa-Fu ChengHui-Shan ChenSiao-Chi WuWei-Heng HungHeng-Chung ChenChang-Lun HuangChing-Yuan ChengBing-Yen WangPublished in: PloS one (2022)
Esophagectomy with adjuvant chemoradiotherapy provided better survival than definitive chemoradiotherapy in clinical II/III esophageal squamous cell carcinoma. However, more data are needed to conduct a convincing conclusion in clinical stage I patients.